Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,235 USD | +7,97 % | +15,08 % | -80,89 % |
Resumen de negocios
Número de empleados: 14
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01/05/12 |
Michael Byrnes
DFI | Director of Finance/CFO | 47 | 01/12/20 |
Douglas Warner
CTO | Chief Tech/Sci/R&D Officer | 52 | 08/08/22 |
Mark Densel
PRN | Corporate Officer/Principal | - | 01/11/18 |
Mayank J. Gandhi
PRN | Corporate Officer/Principal | 47 | 26/09/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01/05/12 |
Director/Board Member | 54 | 25/08/21 | |
Caroline Loewy
BRD | Director/Board Member | 58 | 11/09/23 |
Brian Gallagher
CHM | Chairman | 54 | 01/01/20 |
Barbara Klencke
BRD | Director/Board Member | 66 | 01/11/21 |
Elizabeth Bhatt
BRD | Director/Board Member | 56 | 25/08/21 |
Director/Board Member | 51 | 15/02/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 4 716 409 | 3 553 586 ( 75,35 %) | 0 | 75,35 % |
Información de la empresa
eFFECTOR Therapeutics, Inc.
142 North Cedros Avenue Suite B
92075, Solana Beach
+
http://www.effector.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-80,89 % | 9,74 M | |
-3,24 % | 102 mil M | |
+1,68 % | 96,29 mil M | |
+2,13 % | 22,18 mil M | |
-15,73 % | 21,2 mil M | |
-9,21 % | 18,31 mil M | |
-39,98 % | 17,38 mil M | |
-14,52 % | 16,36 mil M | |
+5,76 % | 13,97 mil M | |
+33,83 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción EFTR
- Empresa eFFECTOR Therapeutics, Inc.